Researchers at University of Wisconsin Carbone Cancer Center are testing a new pain therapy device for patients with nerve pain following chemotherapy treatments. With 40 percent of chemotherapy patients developing neuropathy it is an important step in finding new, effective treatments. Forty patients will be part of the clinical trial. READ MORE Source: University of Wisconsin
Oxaliplatin has become the standard of care for people with advanced colorectal cancer. It appears to cause nerve damage that may be permanent and worsens even months after treatment ends. Dr. Michael Polydefkis, Johns Hopkins University School of Medicine professor and researcher, is leading a team to find ways of preventing or slowing the damage …
Beth Faiman MSN, CNP, a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects for people with blood and bone marrow cancers. Faiman has worked as a nurse practitioner since 1994 at the Cleveland Clinic Taussig Cancer Center with patients diagnosed …
New Research has Potential to Alleviate Side Effects of Cancer Treatments Read More »
An Air Force reserve squadron out of Westover Air Force Base in Massachusetts, is finding some curious coincidences among the men who served with them. C-123 Provider planes used to spray Agent Orange during the Vietnam war were reassigned to domestic mission in the US. Dozens of these reservists have now been found to be …
Scientists at Cambridge University, London, have identified a gene responsible for regulating chronic pain. Their drug discovery should help drug researchers in their search for more effective, targeted pain-killing medicines. By studying the gene in mice, the were able to show that taking away the gene took away neuropathic pain. The drug will not affect …
Biopharmaceutical company, NeurogesX, announced it submitted a supplemental new drug to the US FDA seeking to expand the label to include an application for the management of pain due to HIV-associated neuropathy. FDA Priority Review status is given to drug candidates that offer major advances in treatment and accelerated the standard review time. HIV-PN is …
At Kerman University of Medical Sciences in Kerman, Iran, researchers investigated the possible effects of olive leaf extract on in vitro and in vivo models of diabetic peripheral neuropathy. Their results suggest that olive leaf extract inhibits high glucose-induced neural damage and suppresses diabetes-induced thermail hyperalgesia, an increased sensation to pain. READ MORE Source: PubMed
Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by the NIH to develop a new treatment for preventing nerve damage. “This is a case of ‘bench to bedside’ research,” Dr. Fink says. READ MORE …
U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage Read More »
Diamyd Medical and the University of Michigan have been awarded a $3M three-year NIH grant to develop a product for use in preventing chemo-induced neuropathy. The product could be administered to cancer patients before they start chemotherapy treatments. READ MORE Source: Genetic Engineering & Biotechnology News
Dr. Bryan Schneider, MD, associate professor of medicine at Indiana University School of Medicine, was announced as the recipient of a $450,000 grant to further his research on the relationship between taxane-induced neuropathy and clinical outcomes with other chemotherapy treatments. About one-third of patients who receive chemotherapy with a taxane develop neuropathy. His research aims …
